RNA, U6 small nuclear 228, pseudogene (RNU6-228P)

RNA, U6 small nuclear 228, pseudogene (RNU6-228P) is classified as a pseudogene of a small nuclear RNA (snRNA), specifically related to the U6 spliceosomal RNA gene family[2][6]. U6 snRNA genes encode for components of the spliceosome, a molecular machine involved in the removal of introns from pre-mRNA during splicing—a crucial aspect of gene expression in eukaryotes[1][7]. However, RNU6-228P itself is a pseudogene, meaning it is a genomic sequence that resembles a known gene but is generally considered nonfunctional due to the lack of required promoters, regulatory elements, or due to sequence disruptions that prevent its transcription and function[4][5]. U6 snRNA pseudogenes are prevalent in the human genome, often arising through gene duplication or retrotransposition processes, but unlike functional U6 snRNAs, they do not contribute to splicing or other known biological functions[4][5]. There is no evidence that RNU6-228P is translated or processed, nor does it serve as a protein-coding gene or an active regulatory non-coding RNA. There are no known drugs, disease associations, biomarker roles, or therapeutic applications for RNU6-228P, nor does it act as a receptor, enzyme, transporter, or any type of canonical drug target[2][4][6]. Pseudogenes are not generally considered therapeutic targets, although in rare cases some pseudogenes may acquire regulatory roles; there is no data indicating this for RNU6-228P. Summary: RNU6-228P is a non-functional RNA pseudogene related to the U6 snRNA family, with no known biological activity, disease association, or drug interactions. It is not considered a therapeutic target and is included in databases for genomic annotation purposes only[2][4][6].

Other names

RNU6-228PRNA, U6 small nuclear 228, pseudogene